Yamakawa T, Miyata S, Ogawa N, Koshikawa N, Yasumitsu H, Kanamori T, Miyazaki K
Biosciences Research Laboratory, Mochida Pharmaceutical Co. Ltd., Tokyo, Japan.
Biochim Biophys Acta. 1998 Jan 21;1395(2):202-8. doi: 10.1016/s0167-4781(97)00149-8.
A novel trypsin inhibitor (P25TI) with an apparent molecular size of 25 kDa has previously been purified from the culture medium of human glioblastoma cells. In this study, the cDNA encoding P25TI was isolated by the polymerase chain reaction (PCR) screening system, and its complete amino acid sequence was determined. The cDNA consisted of 1440 nucleotides and encoded a sequence of 258 amino acids. The deduced structure of P25TI seemed to consist of a putative signal peptide sequence (residues 1-25), a propeptide sequence (26-60) and a mature protein (residues 61-258). The P25TI sequence has no homology to other proteinase inhibitors, but has similarity to insect venom allergens, mammalian testis-specific proteins and plant pathogenesis-related proteins. P25TI mRNA was frequently expressed in human neuroblastoma and glioblastoma cell lines. Although Northern blotting analysis failed to detect P25TI mRNA in various human tissues, PCR analysis showed its expression in the brain, placenta and lymphocytes.
一种表观分子大小为25 kDa的新型胰蛋白酶抑制剂(P25TI)先前已从人胶质母细胞瘤细胞的培养基中纯化出来。在本研究中,通过聚合酶链反应(PCR)筛选系统分离出编码P25TI的cDNA,并确定了其完整的氨基酸序列。该cDNA由1440个核苷酸组成,编码一个258个氨基酸的序列。推导的P25TI结构似乎由一个假定的信号肽序列(第1-25位氨基酸)、一个前肽序列(26-60位)和一个成熟蛋白(61-258位)组成。P25TI序列与其他蛋白酶抑制剂无同源性,但与昆虫毒液过敏原、哺乳动物睾丸特异性蛋白和植物病程相关蛋白具有相似性。P25TI mRNA在人神经母细胞瘤和胶质母细胞瘤细胞系中频繁表达。尽管Northern印迹分析未能在各种人体组织中检测到P25TI mRNA,但PCR分析显示其在脑、胎盘和淋巴细胞中表达。